{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:32:18Z","timestamp":1791135138251,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thorax"],"published-print":{"date-parts":[[1997,4,1]]},"DOI":"10.1136\/thx.52.2008.s89","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T19:40:22Z","timestamp":1263238822000},"page":"S89-S91","source":"Crossref","is-referenced-by-count":2,"title":["Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis"],"prefix":"10.1136","volume":"52","author":[{"given":"D. A.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"733","article-title":"Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline","volume":"111","author":"Wood, R.E.; Wanner, A.; Hirsch, J.; Farrell, P.M.","year":"1975","unstructured":"Wood RE, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis 1975;111: 733\u20138.","journal-title":"Am Rev Respir Dis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1748-1716.1986.tb08027.x","article-title":"Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen","volume":"128","author":"Erjefalt, I.; Persson, C.G.A.","year":"1986","unstructured":"Erjefalt I, Persson CGA. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand 1986;128:653\u20134.","journal-title":"Acta Physiol Scand"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/oxfordjournals.bmb.a072584","article-title":"Immunology of cystic fibrosis","volume":"48","author":"Warner, J.O.","year":"1992","unstructured":"Warner JO. Immunology of cystic fibrosis. Br Med Bull 1992;48:893\u2013911.","journal-title":"Br Med Bull"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ppul.1950090204","article-title":"Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis","volume":"9","author":"Pattishall, E.N.","year":"1990","unstructured":"Pattishall EN. Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis. Pediatr Pulmonol 1990; 9:80\u20135.","journal-title":"Pediatr Pulmonol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1378\/chest.99.5.1088","article-title":"A controlled trial of long-term bronchodilator therapy in cystic fibrosis","volume":"99","author":"Eggleston, P.A.; Rosenstein, B.J.; Stackhouse, C.M.; Mellits, D.; Baumgardner, R.A.","year":"1991","unstructured":"Eggleston PA, Rosenstein BJ, Stackhouse CM, Mellits D, Baumgardner RA. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest 1991;99:1088\u201392.","journal-title":"Chest"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0022-3476(73)80085-X","article-title":"The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis","volume":"82","author":"Landau, L.I.; Phelan, P.D.","year":"1973","unstructured":"Landau LI, Phelan PD. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr 1973;82:863\u20138.","journal-title":"J Pediatr"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ppul.1950080107","article-title":"Variability of pulmonary function tests in cystic fibrosis","volume":"8","author":"Cooper, P.J.; Robertson, C.G.; Hudson, I.L.; Phelan, P.D.","year":"1990","unstructured":"Cooper PJ, Robertson CG, Hudson IL, Phelan PD. Variability of pulmonary function tests in cystic fibrosis. Pediatr Pulmonol 1990;8:16\u201322.","journal-title":"Pediatr Pulmonol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/0140-6736(93)92423-Q","article-title":"Clinical management of pulmonary disease in cystic fibrosis","volume":"341","author":"Fiel, S.B.","year":"1993","unstructured":"Fiel SB. Clinical management of pulmonary disease in cystic fibrosis. Lancet 1993;341:1070\u20134.","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1378\/chest.104.3.842","article-title":"The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis","volume":"104","author":"Sanchez, I.; De Koster, J.; Holbrow, J.; Chernick, V.","year":"1993","unstructured":"Sanchez I, De Koster J, Holbrow J, Chernick V. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis. Chest 1993;104: 842\u20136.","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.95.4.861","article-title":"The inhaled bronchodilators ipratropium bromide and metaproteronol in adults with cystic fibrosis","volume":"95","author":"Weintraub, S.J.; Eschenbacher, W.L.","year":"1989","unstructured":"Weintraub SJ, Eschenbacher WL. The inhaled bronchodilators ipratropium bromide and metaproteronol in adults with cystic fibrosis. Chest 1989;95:861\u20134.","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ppul.1950130109","article-title":"Efficacy of salbutamol and ipratropium bromide in decreasing bronchial reactivity in children with cystic fibrosis","volume":"13","author":"Avital, A.; Sanchez, I.; Chernick, V.","year":"1992","unstructured":"Avital A, Sanchez I, Chernick V. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial reactivity in children with cystic fibrosis. Pediatr Pulmonol 1992;13: 34\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3476(05)80927-8","article-title":"Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis","volume":"120","author":"Sanchez, I.; Holbrow, J.; Chernick, V.","year":"1992","unstructured":"Sanchez I, Holbrow J, Chernick V. Acute bronchodilator response to a combination of beta-adrenergic and anticholinergic agents in patients with cystic fibrosis. J Pediatr 1992;120:486\u20138.","journal-title":"J Pediatr"},{"key":"ref_13","first-page":"7","article-title":"Meconium ileus equivalent in association with nebulized ipratropium bromide in cystic fibrosis","volume":"335","author":"Mulhern, D.; Fitzgerald, M.X.","year":"1990","unstructured":"Mulhern D, Fitzgerald MX. Meconium ileus equivalent in association with nebulized ipratropium bromide in cystic fibrosis. Lancet 1990;335:7\u201310.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1440-1754.1991.tb00337.x","article-title":"Le Souef PN. Inhaled therapy in paediatrics","volume":"27","author":"Sly, P.D.","year":"1991","unstructured":"Sly PD, Le Souef PN. Inhaled therapy in paediatrics. J Paediatr Child Health 1991;27:7\u201310.","journal-title":"J Paediatr Child Health"},{"key":"ref_15","first-page":"207","article-title":"Pulmonozyme rhDNase should not be mixed with other nebulizer medications","volume":"10","author":"Cipolla, D.; Clark, A.; Pearlman, R.; Rosen, R.; Gonda, I.","year":"1994","unstructured":"Cipolla D, Clark A, Pearlman R, Rosen R, Gonda I. Pulmonozyme rhDNase should not be mixed with other nebulizer medications. Pediatr Pulmonol 1994;10(Suppl): 207","journal-title":"Pediatr Pulmonol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","article-title":"Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment","volume":"338","author":"Valerius, N.H.; Koch, C.; Hoiby, N.","year":"1991","unstructured":"Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725\u20136.","journal-title":"Lancet"},{"key":"ref_17","first-page":"65","article-title":"Pseudomonas aeruginosa infection in cystic fibrosis","volume":"58","author":"Hoiby, N.; Flensborg, E.W.; Beck, B.; Friis, B.; Jacobsen, S.V.; Jacobsen, L.","year":"1977","unstructured":"Hoiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Scand J Respir Dis 1977;58:65\u201379.3.","journal-title":"Scand J Respir Dis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/adc.68.4.441","article-title":"How to get drugs into the respiratory tract","volume":"68","author":"O\u2019Callaghan, C.","year":"1993","unstructured":"O\u2019Callaghan C. How to get drugs into the respiratory tract. Arch Dis Child 1993;68:441\u20133.","journal-title":"Arch Dis Child"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJM199203193261207","article-title":"A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis","volume":"326","author":"Hubbard, R.C.; McElvaney, N.G.; Birrer, P.; Shak, S.; Robinson, W.W.; Jolley, C.","year":"1992","unstructured":"Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 1992;326:812\u20135.","journal-title":"N Engl J Med"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/ajrccm\/148.1.145","article-title":"Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis","volume":"148","author":"Ramsey, B.W.; Astley, S.J.; Aitken, M.L.; Burke, W.; Colin, A.A.; Dorkin, H.L.","year":"1993","unstructured":"Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis 1993;148:145\u201351.","journal-title":"Am Rev Respir Dis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(93)92297-7","article-title":"Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis","volume":"342","author":"Ranasinha, C.; Assoufi, B.; Shak, S.; Christiansen, D.; Fuchs, H.; Empey, D.","year":"1993","unstructured":"Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, et al. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet 1993; 342:199\u2013202.","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNAase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs, H.J.; Borowitz, D.S.; Christiansen, D.H.; Morris, E.M.; Nash, M.L.; Ramsey, B.W.","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW. Effect of aerosolized recombinant human DNAase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637\u201342.","journal-title":"N Engl J Med"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem, E.; Reisman, J.; Corey, M.; Canny, G.J.; Levison, H.","year":"1992","unstructured":"Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187\u201391.","journal-title":"N Engl J Med"},{"key":"ref_24","first-page":"8","article-title":"A multicenter, double-blind, placebo-controlled study to evaluate the safety and efficacy of aerosolized rhDNase therapy in patients with cystic fibrosis who have advanced lung disease","volume":"10","author":"Johnson, C.","year":"1994","unstructured":"Johnson C. A multicenter, double-blind, placebo-controlled study to evaluate the safety and efficacy of aerosolized rhDNase therapy in patients with cystic fibrosis who have advanced lung disease. Pediatr Pulmonol 1994;10(Suppl): S8.2.","journal-title":"Pediatr Pulmonol"},{"key":"ref_25","first-page":"404","article-title":"Consensus conference: practical applications of Pulmozyme","volume":"17","author":"Ramsey, B.W.; Dorkin, H.L.","year":"1994","unstructured":"Ramsey BW, Dorkin HL. Consensus conference: practical applications of Pulmozyme. Pediatr Pulmonol 1994;17: 404\u20138.","journal-title":"Pediatr Pulmonol"},{"key":"ref_26","article-title":"Guidelines for the treatment of cystic fibrosis [CF] with dornase alpha","author":"Pulmozyme","year":"1994","unstructured":"Cystic Fibrosis Trust. Guidelines for the treatment of cystic fibrosis [CF] with dornase alpha [Pulmozyme]. London: Cystic Fibrosis Trust, 1994."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJM199409083311011","article-title":"Evolution of therapy for cystic fibrosis","volume":"331","author":"Davis, P.B.","year":"1994","unstructured":"Davis PB. Evolution of therapy for cystic fibrosis. N Engl J Med 1994;331:672\u20133.","journal-title":"N Engl J Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thx.52.2008.S89","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T20:47:40Z","timestamp":1550263660000},"score":1,"resource":{"primary":{"URL":"http:\/\/thorax.bmj.com\/cgi\/doi\/10.1136\/thx.52.2008.S89"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":27,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[1997,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/thx.52.2008.s89","relation":{},"ISSN":["0040-6376"],"issn-type":[{"value":"0040-6376","type":"print"}],"subject":[],"published":{"date-parts":[[1997,4,1]]}}}